Fischer candidacy plagued by flawed selection

Stanley Fischer  / Photo: Reuters
Stanley Fischer / Photo: Reuters

It is embarrassing that Stanley Fischer should be subject to the controversy of his selection to be a candidate for Bank Hapoalim's board

After a stormy 2019, it seemed like plain sailing for Bank Hapoalim (TASE: POLI) in 2020. Dov Kotler won an intensive race to replace Arik Pinto as CEO and the US tax evasion case was finally settled.

But then in June chairman Oded Eran unexpectedly fell ill and died and was replaced by Reuven Krupnick, a respected member of the board of directors. Things seemed to have calmed down until yesterday when former Bank of Israel Governor and former US Fed Vice Chairman was named as a candidate for the board of directors.

Fischer is a world class economist and there are few people like him, if any, in Israel. He has vast experience as a macroeconomist on the world stage. Although he is not assured of being selected to sit on the board, his chances must be very good and among other things it would sit well with Hapoalim's foreign investors (of which there are many) and its institutional investors. His age, 76, is his only possible disadvantage.

It is also clear that Fischer would be no ordinary director and perhaps he could be seen as a future chairman, although Krupnick was only recently appointed and has the full confidence of the board and the Bank of Israel.

There would be a certain irony about Fischer joining Hapoalim's board. He has an interesting connection to current norms of 'proper corporate governance' in the world of banking. As Governor of the Bank of Israel he gave his full backing to then Supervisor of Banks Rony Hizkiyahu to oust Bank Hapoalim chairman Dan Dankner. Controlling shareholder Shari Arison tried to stand up against Fischer but failed.

The current struggle is not so much the appointment of Stanley Fischer and the threat to the dominance of Reuven Krupnick as chairman. The struggle is also over the composition of the board of directors in the broadest sense. The committee for choosing directors under the Bank of Israel did not approve the continuation of Dalia Lev on the board, which essentially means she was ousted. This is dramatic enough in itself. Lev was involved in approving Dov Kotler as CEO, ending the tradition whereby the CEO is promoted from within, as well as closing the US tax evasion case. She was considered close to Krupnick. Does this mean that Hapoalim is on the way to a de facto struggle over the chairmanship?

Either way the behavior of the Emeritus Judge Moshe Gal who heads the committee for choosing bank directors seems like an example of not doing as you demand from others by those responsible for corporate governance and regulation, who set the rules for others, but break the rules when it's convenient for them. Even if there is no disputing the leading and unique status of Fischer, there was here perhaps a trampling on the rules of proper governance in order to push his candidacy through - even if it was 'constitutional.'

The committee yesterday put out a routine announcement in which the candidates were listed and then it was mentioned that David Avner, a member of the committee who represents Bank Hapoalim had resigned. Only afterwards following a storm of criticism did the committee see fit to be transparent and reveal why there had been a disagreement between Avner and the other members of the committee because a vote had been taken before a replacement for Krupnick had been named. Krupnick had been the other Hapoalim representative on the committee but had stepped down when he became chairman of the bank.

David Avner might be right that the committee's behavior was flawed but on the other hand is it appropriate that a candidate of Stanley Fischer's caliber should be subject to the embarrassing controversy that the issue is receiving?

Published by Globes, Israel business news - en.globes.co.il - on August 27, 2020 © Copyright of Globes Publisher Itonut (1983) Ltd. 2020

Stanley Fischer  / Photo: Reuters
Stanley Fischer / Photo: Reuters
Dr. R  credit: Jonathan Bloom Wounded in his tank, now R develops protection systems

"I was close to death, but it sharpened my awareness of the products we develop for the IDF."

Ella Kenan  credit: Yossi Cohen A fighter of fake news about Israel

Ella Kenan saw online denial of October 7 happening straightaway. "I realized we had 24 hours, or we were doomed"

Liron Horshi credit: Jonathan Bloom Wiz's talent manager nurtures $1b workforce

Wiz's $32 billion sale to Google was rooted in the cloud security product if offers but could not have been achieved without the quality of its employees built by human resources chief Liron Horshi.

Yoav Shoham  credit: Eyal Izhar Yoav Shoham: AI isn't too smart, it's too dumb

AI21 Labs founder and CEO Prof. Yoav Shoham talks to "Globes" about dubious doomsday predictions, what should really concern us, and what could make Israel a global AI leader.

Record public company profits  credit: Tali Bogdanovsky Profits peak, but reckoning awaits

In what may seem a paradox, profits grew in almost every sector on the Tel Aviv Stock Exchange last year, but the boom was largely fueled by government spending.

Insightec COO and general manager Eyal Zadicario credit: Ness Productions After 25 years of losses Insightec focuses on profit

Insightec COO and general manager Eyal Zadicario tells "Globes" about himself and the Israeli ultrasound company's long battle to change the medical world.

Amit Shaked credit: Tomer Lesher Driven to succeed but balancing ambition with wellbeing

At just 14, cybersecurity company Rubrik VP Amit Shaked began a B.Sc. in Computer Science and Math and mapped out his entire future, which included IDF service in the 8200 unit, and an inevitable huge startup exit.

Advs. Roy Keidar and Netanella Treistman credit: Nicky Westphal AI blind spot startups can no longer afford to ignore

How AI governance can assist startups and enhance their ability to succeed.

Dr. Ola Gutzeit  credit: Ketty Hakim The doctor breaking new ground in fertility

"We know nothing about the female reproductive system," says Dr. Ola Gutzeit of Rambam Hospital. She seeks to change that, and hence change IVF for the better.

Google CEO Sundar Pichai  crediit: Shutterstock Why Google is paying so much for Wiz

Lagging its competitors in cloud and AI, and facing challenges to its core advertising business, Google could be looking to spend its way out of trouble.

Donald Trump speaking on the deck of the USS Gerald R. Ford  at its launch in 2017 credit: Reuters/Jonathan Ernst Houthis between hammer and anvil

President Trump appears determined to end the Houthi threat to shipping, while Iran has abandoned the last active arm of its "axis of resistance."

Prof. Douglas Irwin  credit: Inbal Marmari "We will all be poorer"

Prof. Douglas Irwin, an expert on international trade, talks to "Globes" about the impact of President Trump's tariffs policy, and what Israel can do about it.

Rooftop solar panels credit: Shutterstock Does it pay for homes to install rooftop solar panels?

As the Israeli government steps up efforts to encourage homeowners to produce their own electricity from rooftop panels, "Globes" investigates the advantages and pitfalls.

Dop Elbit banner at London's Allianz HQ credit: Reuters PA Images Violence against Israeli defense cos in UK escalates

"The Sunday Times" has investigated Palestine Action, a radical left-wing group that targets Israeli defense companies, their subsidiaries, and corporations and banks with any connection to Israel.

UnitedHealth founder Richard Burke credit: Ken Easley UnitedHealth founder: US health system is broken

In an exclusive interview Richard Burke talks about the murder of the company's CEO, Donald Trump, his love for Israel, and investment in Israeli startup Korro AI.

Left to right: Karin Goldberg, Einav Laser, Dr. Arseniy Lobov, Dr. Paola Antonello, Dr. Merav Shmueli, and Prof. Yifat Merbl (center in black)  credit: Weizmann Institute Israeli scientists' discovery could lead to new antibiotics

Prof. Yifat Merbl of the Weizmann Institute and her team have found a natural source of anti-microbial substances in the "garbage can" of human cells.

Twitter Facebook Linkedin RSS Newsletters גלובס Israel Business Conference 2018